SG132687A1 - SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF - Google Patents

SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF

Info

Publication number
SG132687A1
SG132687A1 SG200703821-9A SG2007038219A SG132687A1 SG 132687 A1 SG132687 A1 SG 132687A1 SG 2007038219 A SG2007038219 A SG 2007038219A SG 132687 A1 SG132687 A1 SG 132687A1
Authority
SG
Singapore
Prior art keywords
splice variants
compositions
erbb ligands
erbb
ligands
Prior art date
Application number
SG200703821-9A
Other languages
English (en)
Inventor
Daniel Harari
Original Assignee
Agos Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agos Biotech Ltd filed Critical Agos Biotech Ltd
Publication of SG132687A1 publication Critical patent/SG132687A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG200703821-9A 2003-08-19 2004-08-19 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF SG132687A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49589803P 2003-08-19 2003-08-19

Publications (1)

Publication Number Publication Date
SG132687A1 true SG132687A1 (en) 2007-06-28

Family

ID=34193356

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200703821-9A SG132687A1 (en) 2003-08-19 2004-08-19 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF

Country Status (7)

Country Link
US (1) US20090131308A1 (fr)
EP (1) EP1660628A4 (fr)
CN (1) CN101309930A (fr)
AU (2) AU2004265512B2 (fr)
CA (1) CA2536146A1 (fr)
SG (1) SG132687A1 (fr)
WO (1) WO2005017096A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090312265A1 (en) * 2006-02-10 2009-12-17 Dermagen Ab Novel antimicrobial peptides and use thereof
WO2007132784A1 (fr) * 2006-05-15 2007-11-22 Niigata University Médicament antipsychotique et remède pour une anomalie cognitive contenant un dérivé de l'anthraquinone en tant que matière active
WO2009036167A1 (fr) * 2007-09-14 2009-03-19 Vanderbilt University Ciblage d'une fonction de récepteurs notch3 pour une thérapie du cancer
CN102470157B (zh) * 2009-07-28 2016-08-17 里加赛谱有限公司 广谱erbb配体结合分子及其制备和使用方法
WO2020031204A1 (fr) * 2018-08-08 2020-02-13 Sree Chitra Tirunal Institute For Medical Science And Technology Facteur de croissance transformant (tgf) recombinant à des fins de cicatrisation de plaies et son procédé
AR121035A1 (es) * 2019-04-01 2022-04-13 Lilly Co Eli Compuestos de neuregulina-4 y métodos de uso
US20230145643A1 (en) * 2020-03-31 2023-05-11 Songhomitra Panda-Jonas Agents for use in the therapeutic or prophylactic treatment of retinal pigment epithelium associated diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587022T2 (de) * 1984-02-17 1993-06-17 Genentech Inc Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
US5624816A (en) * 1992-07-30 1997-04-29 University Of Miami Transmembrane glycoprotein ASGP-2: nucleotide sequences and recombinant production of proteins
WO1994003644A1 (fr) * 1992-08-10 1994-02-17 Cambridge Neuroscience, Inc. Inhibiteurs de la proliferation cellulaire, preparation et utilisation
KR100313736B1 (ko) * 1993-06-04 2002-03-21 우에하라 아끼라 사람유래종양세포증식저해인자
US6150502A (en) * 1998-04-29 2000-11-21 Genesis Research & Development Corporation Limited Polypeptides expressed in skin cells
KR20030016233A (ko) * 2000-02-28 2003-02-26 디코드 제네틱스 이에이치에프 사람 정신분열증 유전자
WO2001064876A2 (fr) * 2000-02-28 2001-09-07 Decode Genetics Ehf Gene humain de la schizophrenie

Also Published As

Publication number Publication date
WO2005017096A2 (fr) 2005-02-24
WO2005017096A3 (fr) 2009-03-26
US20090131308A1 (en) 2009-05-21
EP1660628A2 (fr) 2006-05-31
EP1660628A4 (fr) 2010-03-31
AU2004265512A1 (en) 2005-02-24
CA2536146A1 (fr) 2005-02-24
CN101309930A (zh) 2008-11-19
AU2011201152A1 (en) 2011-04-07
AU2004265512B2 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
DE60028970D1 (de) An her2 bindende peptidverbindungen
WO2004048551A3 (fr) Cible destinee a la therapie d'un trouble cognitif
WO2005016962A3 (fr) Compositions et techniques de traitement de maladies liees a l'immunite
HK1110802A1 (en) Use of nucleic acids in the preparation of a medicament for treating melanoma and the composition thereof
WO2007109236A3 (fr) Empreintes digitales micro-arn pendant une mégacaryocytopoïese
WO2005049630A3 (fr) Modulation antisens de l'expression de la proteine de type kinesine 1
NO20034056D0 (no) Proliferative sykdommer
ATE523196T1 (de) Mitotische kinesinhemmer und verfahren zu ihrer verwendung
EA200801711A1 (ru) Пролекарства возбуждающих аминокислот
WO2005002526A3 (fr) Procedes et compositions pour le traitement d'infections virales
WO2006023852A3 (fr) Modulateurs des recepteurs muscariniques
EA200801343A1 (ru) Иммуноглобулины, направленные против nogo
WO2006058294A3 (fr) Modulateurs des recepteurs muscariniques
WO2005030188A3 (fr) Derives de phenyl-piperazine en tant que modulateurs des recepteurs muscariniques
WO2003008543A3 (fr) Modulation antisens de l'expression de la proteine x associee a bcl2
SG149045A1 (en) Novel fused pyrrolocarbazoles
SG149042A1 (en) Novel fused pyrrolocarbazoles
MX2007005054A (es) Proteinas que contienen el factor a de von willebrand y dominios extracelulares del receptor de antrax.
MX2007006382A (es) Moduladores de receptores muscarinicos.
SG132687A1 (en) SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF
ATE551054T1 (de) Verfahren und zusammensetzungen zur behandlung von nephrogenem diabetes insipidus
WO2007120955A3 (fr) Gènes agissant sur les performances de la mémoire humaine
WO2003104397A3 (fr) Modulation antisens de l'expression de la proteine kinase gr 6
ATE372114T1 (de) Verfahren zur erhöhung des testosteronspiegels
WO2003050244A3 (fr) Modulation antisens de l'expression de recepteur etbr-lp-2 couple aux proteines g